Effect of continued folic acid supplementation beyond the first trimester of pregnancy on cognitive performance in the child: a follow-up study from a randomized controlled trial (FASSTT Offspring Trial)

• Published in: BMC medicine 2019-10, Vol.17 (1), p.196-196, Article 196
• Main Authors: McNulty, Helene, Rollins, Mark, Cassidy, Tony, Caffrey, Aoife, Marshall, Barry, Dornan, James, McLaughlin, Marian, McNulty, Breige A, Ward, Mary, Strain, J J, Molloy, Anne M, Lees-Murdock, Diane J, Walsh, Colum P, Pentieva, Kristina
• Format: Article
• Language: English
• Subjects: Analysis; Child; Child development; Child Development - drug effects; Child, Preschool; Childhood; Children; Clinical trials; Cognition; Cognition - drug effects; Cognitive performance; Dietary Supplements; Early childhood education; Female; Folic acid; Folic Acid - administration & dosage; Folic Acid - pharmacology; Follow-Up Studies; Gestational Age; Health aspects; Humans; Male; Neural tube defects; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Pregnant women; Prenatal folic acid; Prevention; Public health; Randomized controlled trial; Retirement benefits
• ISSN: 1741-7015; 1741-7015
• DOI: 10.1186/s12916-019-1432-4

Periconceptional folic acid prevents neural tube defects (NTDs), but it is uncertain whether there are benefits for offspring neurodevelopment arising from continued maternal folic acid supplementation beyond the first trimester. We investigated the effect of folic acid supplementation during trimesters 2 and 3 of pregnancy on cognitive performance in the child. We followed up the children of mothers who had participated in a randomized controlled trial in 2006/2007 of Folic Acid Supplementation during the Second and Third Trimesters (FASSTT) and received 400 μg/d folic acid or placebo from the 14th gestational week until the end of pregnancy. Cognitive performance of children at 7 years was evaluated using the Wechsler Preschool and Primary Scale of Intelligence (WPPSI-III) and at 3 years using the Bayley's Scale of Infant and Toddler Development (BSITD-III). From a total of 119 potential mother-child pairs, 70 children completed the assessment at age 7 years, and 39 at age 3 years. At 7 years, the children of folic acid treated mothers scored significantly higher than the placebo group in word reasoning: mean 13.3 (95% CI 12.4-14.2) versus 11.9 (95% CI 11.0-12.8); p = 0.027; at 3 years, they scored significantly higher in cognition: 10.3 (95% CI 9.3-11.3) versus 9.5 (95% CI 8.8-10.2); p = 0.040. At both time points, greater proportions of children from folic acid treated mothers compared with placebo had cognitive scores above the median values of 10 (girls and boys) for the BSITD-III, and 24.5 (girls) and 21.5 (boys) for the WPPSI-III tests. When compared with a nationally representative sample of British children at 7 years, WPPSI-III test scores were higher in children from folic acid treated mothers for verbal IQ (p